We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

600346:SSEHengli Petrochemical Co., Ltd. Class A Analysis

Data as of 2026-09-13 - not real-time

CN¥17.27

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

At ¥17.27, Hengli Petrochemical Co.,Ltd. shows no decisive moving-average alignment, leaving the trend neutral. Over a rolling month the price has gained 3.3%. Relative strength is 42.1 — neutral — and the MACD signal is bearish. Recent trading has carved out support near ¥16.99 and resistance around ¥19.93.
On valuation the read is undervalued — an earnings multiple of 10.8, absent a reliable peer benchmark. The average analyst target implies 52.8% above today's level. Revenue is growing at 4.6% on a 5.7% profit margin. The 4.75% dividend yield looks covered by current payout levels.
Risk scores 6 out of 10, which is elevated for this asset class. With 30-day volatility of 45.2%, a beta of 0.20 and a maximum drawdown of 43.9%, position sizing matters here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 1 out of 10.

Top Market Events

ad-hoc-news5monHengli Petrochemical Stock: A Key Player in China's Petrochemical Sector for North American...Barron's1monHengli Petrochemical Co. Ltd. AHengli Petrochemical Co., Ltd. is engaged in the manufacture and sale of...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 2/10

Key Factors

  • Trading below the 200-day average of 20.43
  • MACD momentum is negative
  • 30-day volatility of 45.2%

Medium Term

1–3 years
Neutral
Model confidence: 1/10

Key Factors

  • Trading below the 200-day average of 20.43
  • Analyst targets imply +52.8% versus the current price
  • 30-day volatility of 45.2%

Long Term

> 3 years
Neutral
Model confidence: 1/10

Key Factors

  • Analyst targets imply +52.8% versus the current price
  • Negative free cash flow
  • P/E ratio of 10.8

Key Metrics & Analysis

Financial Health

Revenue Growth4.60%
Profit Margin5.75%
P/E Ratio10.8
ROE16.61%
ROA3.24%
Debt/Equity227.53
P/B Ratio1.7
Op. Cash FlowCN¥15.1B
Free Cash FlowCN¥-1442289280

Technical Analysis

TrendNeutral
RSI42.1
SupportCN¥16.99
ResistanceCN¥19.93
MA 20CN¥18.64
MA 50CN¥17.42
MA 200CN¥20.43
MACDBearish
VolumeDecreasing
Fear & Greed Index93.14

Valuation

Fair ValueCN¥4.70
Target PriceCN¥26.40
Upside/Downside52.85%
GradeUndervalued
TypeValue
Dividend Yield4.75%

Risk Assessment

Beta0.20
Volatility45.18%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskHigh
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.